Estimaciones de analistas de Wall Street para Insight Molecular Diagnostics Inc. (IMDX): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-09 | $-0.23 | ||
| 2026-08-10 | $-0.31 | $-0.25 | -22.1% |
| 2026-05-13 | $-0.12 | $-0.26 | +54.1% |
| 2026-03-26 | $-0.72 | $-0.24 | -203.2% |
| 2025-11-10 | $-0.34 | $-0.21 | -61.9% |
| 2025-08-14 | $-0.30 | $-0.23 | -30.4% |
| 2025-05-12 | $-0.26 | $-0.24 | -9.5% |
| 2025-03-24 | $-1.93 | $-0.40 | -382.0% |
Ratios de valoración
| Precio / Valor contable | -6.18 |
| EV / EBITDA | -2.53 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | 0 | 0 | $1.2M | $2.2M | $958000 | $1.5M | $1.9M | $4.1M |
| Coste de Ventas | $387000 | $580000 | $559000 | $344000 | $1.9M | $778000 | $976000 | $1.1M | $1.1M | $3.9M |
| Beneficio Bruto | -$387000 | -$580000 | -$559000 | -$344000 | -$639000 | $1.4M | -$18000 | $413000 | $740000 | $190000 |
| I+D | $5.7M | $7.2M | $6.5M | $6.8M | $9.8M | $5.0M | $7.3M | $9.3M | $9.8M | $15.9M |
| Generales y Administrativos | $5.5M | $11.7M | $8.7M | $15.4M | $23.3M | $20.4M | $21.5M | $13.3M | $13.8M | $17.0M |
| Gastos Operativos | $11.1M | $18.8M | $15.2M | $22.2M | $29.1M | $55.1M | $18.0M | $25.5M | $61.8M | $30.8M |
| Beneficio Operativo | -$11.1M | -$18.8M | -$15.2M | -$22.2M | -$29.7M | -$53.7M | -$18.0M | -$25.1M | -$61.0M | -$30.6M |
| EBITDA | -$11.1M | -$18.3M | -$15.2M | -$21.9M | -$30.5M | -$48.5M | -$13.3M | -$23.1M | -$59.0M | -$47.9M |
| Gastos por Intereses | $28000 | $217000 | $216000 | $299000 | $252000 | $209000 | $83000 | $52000 | $84000 | $109000 |
| Beneficio Antes de Impuestos | -$11.2M | -$19.4M | -$15.8M | -$22.4M | -$31.2M | -$52.9M | -$18.6M | -$24.9M | -$60.7M | -$50.2M |
| Impuestos | 0 | 0 | 0 | 0 | -$1.3M | -$9.3M | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$11.2M | -$19.4M | -$15.8M | -$22.3M | -$29.9M | -$64.1M | -$72.9M | -$27.8M | -$60.7M | -$50.2M |
| BPA | $-8.42 | $-12.83 | $-8.32 | $-8.71 | $-9.14 | $-14.40 | $-20.00 | $-3.75 | $-4.66 | $-1.65 |
| BPA Diluido | $-8.42 | $-12.83 | $-8.32 | $-8.71 | $-9.14 | $-14.40 | $-20.00 | $-3.75 | $-4.66 | $-1.65 |
| Acciones en Circulación (Diluidas) | $1.3M | $1.5M | $1.9M | $2.6M | $3.3M | $4.4M | $5.5M | $7.7M | $13.1M | $30.5M |
Precio
| Precio | $3.58 |
| Capitalización | $116M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: ARMP · CCCC · CDXS · CYBN · IVVD · MIST · OABI
Explorar sector: Healthcare · Medical - Diagnostics & Research
Más secciones de IMDX: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones